Derived from the Finnish word for “to serve”, Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases, we believe we can dramatically enhance quality of life.
View Top Employees from Palvella Therapeutics| Website | https://palvellatx.com/ |
| Revenue | $7 million |
| Funding | $45 million |
| Employees | 16 (12 on RocketReach) |
| Founded | 2015 |
| Address | 125 Strafford Ave Suite 360, Wayne, Pennsylvania 19087, US |
| Phone | (484) 253-1460 |
| Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Palvella Therapeutics employee's phone or email?
Palvella Therapeutics Questions
The Palvella Therapeutics annual revenue was $7 million in 2024.
Pam Swiggard is the Vice President Regulatory Affairs of Palvella Therapeutics.
12 people are employed at Palvella Therapeutics.
Palvella Therapeutics is based in Wayne, Pennsylvania.
The NAICS codes for Palvella Therapeutics are [3254, 32, 325, 32541].
The SIC codes for Palvella Therapeutics are [283, 28].
Top Palvella Therapeutics Employees
-
12
-
23
-
35+
-
ViewWes Kaupinen
Founder and CEO at Palvella Therapeutics
Philadelphia, Pennsylvania, United States21 -
View
Colleen Pellegrini
Associate Director, Site and Trial Management at Palvella Therapeutics
Philadelphia, PA, US45+ -
21
-
45+
Related Companies
